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1. Introduction 
 
Metabolic engineering has been a well established scientific 
discipline for over two decades now [1]. During this period, advances 
in the understanding of the functional role of thousands of genes in 
various organisms, and the development of theoretical and 
experimental tools for determining the flow of metabolites through 
different biochemical pathways [2,3], have provided hints for 
numerous potential cellular targets whose modification can lead to 
optimal metabolism and improved properties.   
More recently, advances in sequencing technologies have resulted 
in an explosion in the number of sequenced microbial genomes, 
revealing a plethora of novel enzymes, biochemical reactions and 
pathways, while the development of efficient methodologies for 
performing directed protein evolution has enabled the engineering of 
enzymes with tailored activities [4,5]. Furthermore, the emergence of 
more global approaches for analysing cell function, such as systems 
biology, have contributed to our understanding of how biochemical 
pathways operate, not in the form of sequential “isolated” reactions, 
but instead as complex, interdependent and dynamic networks of such 
reactions [6]. Finally, synthetic biology has extended the capabilities 
of classical metabolic engineering as it has provided the rationale and 
tools to combine biological components and generate designed gene 
networks, artificial metabolic pathways, and organisms with man-
made genomes [7,8].  
 
 
 
 
 
 
 
 
 
  
 
 
 
These technologies, in combination with the significantly 
advanced analytical tools available today for analyzing levels of DNA, 
RNA, proteins and metabolites in the cell, have enabled the 
development of engineered prokaryotic and eukaryotic organisms with 
the ability to produce a wide array of chemicals useful for research 
and the industry: amino acids [9], antibiotics [10], alkaloids [11], 
isoprenoids [12], vitamines, fragrances, peptides and polyketides [13], 
organic solvents and biofuels [14,15], nutraceuticals, polymers [16] 
and others. 
A prerequisite for the success of classical (forward) metabolic 
engineering is a detailed knowledge of the biochemical pathways 
involved in the biosynthesis of a particular metabolite or in the 
appearance of a desired phenotype. This knowledge is necessary in 
order to be able to make targeted and rationally selected genetic 
modifications. However, a variety of cellular properties important for 
the industry and research, such as resistance to organic solvents and 
optimal production of certain metabolites, are still poorly 
characterized and frequently arise from modifications in pathways 
that involve genes of unknown function or ones that would be 
impossible to predict by rational engineering, possibly because they 
act by indirect or compensatory mechanisms. In these cases, where 
educated guesses about possible interventions are hard or impossible 
to make, a different strategy can be applied, which is termed “inverse 
metabolic engineering” [17]. In this type of metabolic engineering, the 
desired property is first linked to a readily detectable phenotype, e.g. 
changes in cell growth, color, fluorescence etc. Then, random genetic 
modifications, such as chromosomal point mutations, gene deletions, 
gene over-expressions etc., are introduced into the host so that a 
library of cells with genetic diversity is generated. This library is then 
screened and the clones that exhibit the desired phenotype are 
identified. Genetic analysis of the isolated clones subsequently can 
reveal the factors responsible for the improved properties and lead to 
enhanced understanding of the (previously unidentified) biochemical 
processes involved.  
Given the availability of an effective genetic screening or selection 
system for the desired property, the potential success of an inverse 
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metabolic effort is highly dependent on the level and quality of 
genetic diversity which can be generated. Here, we review 
combinatorial approaches for generating genetic diversity within a 
host cell population, and discuss the applications of these 
methodologies in inverse metabolic engineering. Emphasis is placed 
on approaches which have been developed in recent years.                
 
2. Classical approaches in inverse metabolic engineering 
 
Spontaneously acquired mutations leading to increased fitness 
under specific growth conditions is the classical adaptive evolution 
paradigm. This has been used by mankind for millennia, and by the 
industry and academia for decades in order to generate useful 
organisms for a variety of applications. Numerous successes in inverse 
metabolic engineering mediated through spontaneous mutagenesis 
have been reported and include increased tolerance to isobutanol and 
ethanol [18,19], growth on citrate [20]; production of D-lactate [21] 
and hard-to-express recombinant proteins in Escherichia coli [22]; 
production of 1,3-propanediol in Klebsiella pneumoniae [23]; xylose 
and galactose utilization in Saccharomyces cerevisiae [24,25]. Analysis 
of the genetic lesions that lead to improved phenotypes in 
spontaneously evolved strains used to be a complicated or impossible 
process for variants carrying multiple and distantly located mutations, 
but the recent development of -omics technologies coupled with the 
increased throughput and decreased cost of sequencing technologies 
has made this a very tractable task [19-21,26].   
 
Libraries of cells containing lesions randomly distributed over the 
entire chromosome can be readily generated by exposing a population 
to sub-lethal doses of mutagenic chemicals, such as N-methyl-N-
nitro-N-nitrosoguanidine and ethyl methanesulfonate or other 
mutagenic agents, such as UV irradiation. The use of such agents has 
resulted in the development of microbial strains with the ability to 
produce enhanced amounts of isobutanol [27], full-length IgG 
antibodies [28] and membrane proteins [29].   
 
Genes whose products have a negative impact on a desired 
property can be readily identified by transposon mutagenesis. This 
type of mutagenesis results in random insertions of transposable 
elements throughout the genome with concomitant functional 
disruption of the gene sequence that received the insertion. 
Transposon mutagenesis has led to the development of improved 
strains and the identification of inhibitory roles for genes involved in 
the production of biomass [30], lycopene [31], and membrane 
proteins [32] in E. coli; riboflavin production in Bacillus subtilis [33]; 
and poly-3-hydroxybutyrate in Synechocystis sp. PCC6803 [34], to 
name a few examples. Very useful tools for studying the effect of gene 
knockouts is the Keio collection, a publicly available library of all 
single knockouts of all the non-essential E. coli K-12 genes [35] and 
the yeast deletion collection [36]. The utility of these libraries in 
inverse metabolic engineering has already been demonstrated [37] and 
it is expected that such libraries will be increasingly used in the 
coming years. 
 
Genes, gene fragments or fragments of entire operons that favorably 
affect a desired property can be isolated from vector libraries co-
expressing genomic fragments. Genomic libraries have been screened 
in order to identify genes that enhance alcohol tolerance/production 
and galactose fermentation in S. cerevisiae [38-40]; acetate and 
butanol tolerance [41,42], lycopene [43] and membrane protein 
production [44] in E. coli; butyrate tolerance in Clostridium 
acetobutylicum [45], and in other cases. In addition, individual 
enhancer genes can be identified using the ASKA library, a library of 
all the E. coli open reading frames (ORFs) transcribed from the 
strong and inducible T5lac promoter [46] or the FLEXgene 
collection, an analogous library encoding yeast ORFs from S. 
cerevisiae [47], both of which are publicly available. Again, such 
collections have already been used successfully for inverse metabolic 
engineering applications [48,49]. To explore the functional genomic 
content of unculturable organisms, similar screens can also be carried 
out by constructing and screening metagenomic libraries [50].  
Finally, additive positive effects from genes and/or operons 
distantly located within a genome can be identified by a recently 
developed tool termed coexisting/coexpressing genomic libraries 
(CoGeLs) [51]. CoGeLs allow the simultaneous screening of two 
genomic libraries encoded in different vectors with compatible origins 
of replication which can coexist in the same host. These vectors can 
be regular bacterial plasmids that contain small- or medium-size 
inserts (up to 10 kbases) or fosmids, which are low-copy number 
vectors where large DNA fragments (~40 kbases) can be inserted. 
Using a combination of two plasmid-encoded E. coli genomic 
libraries, Nicolaou et al. demonstrated that CoGeLs can be used to 
identify combinations of distantly located factors that impart 
increased acid resistance in E. coli [51].               
 
3. Recently developed approaches in inverse metabolic 
engineering 
 
In recent years, a number of new approaches have been developed 
that attempt to create more “global” changes on cellular pathways and 
physiology as means of generating complex phenotypes more 
effectively. The majority of those strategies aim at modifying the 
transcriptional landscape of an organism, e.g. by generating libraries of 
randomized transcription factors or by mutating components of the 
RNA polymerase. Since certain components of the transcriptional 
machinery in prokaryotic as well as eukaryotic organisms regulate the 
expression of a wide repertoire of genes, subtle changes in these 
components can have a pronounced effect on the transcriptome of the 
cell, thus offering the potential for the emergence of diverse and 
complex phenotypes [52]. Some examples of these methods are 
described below and are summarized in Table 1. 
 
Zinc fingers are highly specific DNA-binding protein domains 
which recognize three-base pair sequences and are found in many 
proteins that regulate transcription in a variety of organisms. One 
transcription factor can include several of these motifs. The ones that 
contain more fingers recognize larger stretches of DNA and are, 
generally, more specific about the genomic loci that they bind. 
Currently, at least one natural or engineered zinc finger exists for 
every possible triplet of DNA bases (4x4x4=64 possible triplets) 
[53-55]. Park et al. took advantage of the wide repertoire of DNA-
binding specificities and the highly modular way with which these 
proteins can be assembled [56] to generate libraries of artificial 
transcriptional activators and repressors that can activate or silence 
practically any gene within a eukaryotic genome [57], with the 
ultimate goal of evolving complex phenotypes. First, they selected 40 
and 25 zinc fingers with diverse DNA-binding specificities and used  
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them to create random combinatorial combinations of three- and 
four-finger  proteins,  respectively. They then fused these randomly 
assembled finger triads and quadrads to a transcriptional activation 
domain, a transcriptional repressor domain, or no domain, to generate 
a library of artificial factors which can potentially regulate the 
transcription of genes close to their DNA-binding site. Expression of 
the generated three- and four-finger libraries fused to the Gal4 
activation domain, the Ume6 repression domain, or no domain in S. 
cerevisiae resulted in the emergence of novel phenotypes such as 
growth arrest, and resistance to heat, osmotic stress, and the 
mycocidal antibiotic ketoconazole [57]. Replacement of the activation 
and repression domains with p65 and the Krüppel-associated 
box (KRAB), expression of the transcription factor library in 
mammalian cells, and screening for the emergence of complex 
phenotypes resulted in the identification of (i) one p65-containing 
zinc finger activator, which could induce neurogenesis of the mouse 
neuroblastoma cell line Neuro2A; (ii) one zinc finger activator that 
induced the differentiation of murine myoblasts to osteoblasts; and 
(iii) one inhibitor and one enhancer of cell proliferation [57]. 
Artificial zinc finger transcription factors can also be used to impart 
novel phenotypes in lower organisms such as bacteria, either in the 
absence of a transcriptional regulation domain [58], or in the presence 
of an activator, such as the cAMP receptor protein (CRP) [59,60].         
 
gTME is another powerful new tool that enables the 
reprogramming of the cellular transcriptome through random 
mutagenesis of specific components of the global transcriptional 
Figure 1. Schematic representation of the MAGE approach. First, specific genes/genomic locations known/suspected to be involved in a particular cellular 
phenotype are targeted for modification. Then, synthetic oligonucleotides that introduce insertions, deletions, missense mutations, or other types of genetic 
lesions are synthesized and introduced into the target cell host by electroporation. Subsequently, the action of the λ Red recombinase system assists the 
introduction of the designed lesions into the target genomic loci. Finally, the beneficial mutations are selected and enriched by performing cycles of genetic 
screening or selection. The beneficial genomic alterations can be readily identified by DNA sequencing of the targeted genomic locations.    
 
 
Inverse metabolic engineering approaches 
3 
Volume No: 3, Issue: 4, October 2012, e201210021 Computational and Structural Biotechnology Journal | www.csbj.org 
machinery of a microbial organism. Initially, the components which 
were selected for mutagenesis were the E. coli general sigma factor σ70 
[61], and the S. cerevisiae TATA-binding transcription factor Spt15p 
and the TATA-binding protein associated factor Taf25p [62]. The 
rationale behind the choice of σ70 as a target was that it regulates the 
expression of about 1,000 genes, which are important for normal 
exponential growth in bacteria [63], while missense mutations in 
rpoD, the gene encoding σ70, have been shown to result in changes in 
the binding preferences of the RNA polymerase-σ factor complex 
[64,65]. Similarly, Spt15p and Taf25p were chosen because they are 
regarded as two of the main DNA-binding proteins that regulate the 
promoter specificities of the three RNA polymerases in yeast. These 
factors were mutated by error-prone PCR to form combinatorial 
libraries of random mutant alleles, cloned into appropriate vectors, 
and expressed in E. coli and yeast strains that contained the native 
genomic copy of the corresponding factor. After performing relevant 
genetic screens and selections, variants of the targeted factors were 
identified, whose expression resulted in the emergence of industrially 
important properties. In E. coli, several multiple point and truncation 
rpoD mutants were isolated that conferred increased tolerance to 
ethanol (up to 60 g/L), to sodium dodecyl sulfate (SDS), and to 
both ethanol and SDS, as well as enhanced production of lycopene 
(10-50% increase depending on the parental strain) [61]. In yeast, a 
triple point variant of Spt15p was isolated that exhibited a 13-fold 
increase in growth at specific glucose concentrations and a volumetric 
production of ethanol enhanced by ~70% compared to the parental 
S. cerevisiae strain [62].  
After this initial success, a number of reports described the use of 
gTME to evolve bacterial and yeast strains exhibiting an array of 
industrially important phenotypes and properties, such as enhanced 
production of hyaluronic acid [66], L-tyrosine [67], and lactate [68]; 
increased to tolerance to ethanol, butanol, acetate, butyrate, 
lignocellulosic hydrolysates, and osmotic stress [69-73]; improved 
capacity to ferment xylose [74]; and regulated biofilm formation and 
dispersal [75,76]. Furthermore, these studies showed that appropriate 
protein targets for gTME are not limited to σ70, Spt15p, and Taf25p, 
but can also be applied to additional components of the 
transcriptional machinery of an organism which can simultaneously 
affect the transcriptional profile of multiple genes, such as the α 
subunit of the E. coli RNA polymerase [67], CRP [69,72], the 
histone-like nucleoid structuring protein H-NS [76], and the H-NS-
interacting haemolysin expression modulating protein Hha [75]. In 
certain cases, it may be beneficial to target more than one of these 
factors simultaneously [77].   
It is interesting to mention that improved cellular properties can 
be engineered not only by targeting endogenous global transcriptional 
regulators, but also by applying gTME to targets derived form 
heterologous hosts. For example, Chen et al. isolated variants of the 
global regulator IrrE from Deinococcus radiodurans (a bacterium 
with very high levels of resistance to radiation) that enhanced stress 
tolerances when expressed in E. coli [73]. However, not all global 
transcriptional regulators are appropriate gTME targets for a given 
property. This was demonstrated in the case of the E. coli stationary 
phase sigma factor σS, where effective variants for enhancing 
hyaluronic acid production in E. coli could not be identified, despite 
the fact that multiple enhancer variants could be identified when σ70 
was subjected to mutagenesis [66]. Of course, one cannot rule out the 
possibility that σS variants useful for hyaluronic acid production in 
bacteria could exist but, due to the limitations in combinatorial 
protein library construction, they were not present in the screened 
rpoS library.  Finally, but very importantly, transcriptional regulators 
which have been engineered by gTME are not only useful for 
conferring improved phenotypes to standard laboratory strains such as 
E. coli K12, but also for other microbes of industrial interest, such as 
Lactobacillus plantarum [68]. Once functional variants of gTME 
targets have been identified, the changes within the transcriptional 
landscape responsible for the appearance of the beneficial properties 
can be identified by DNA microarray analysis. 
Based on the data described above, one can now claim that gTME 
is a relatively well established approach for inverse metabolic 
engineering applications. Through the already generated results, a 
number of important conclusions have been drawn, which will 
provide useful guidance for future gTME efforts. For example, 
Stephanopoulos and co-workers have tested gTME target libraries 
generated by low, medium, and high mutagenesis frequencies and have 
proposed that high-error rate mutagenic PCR pools exhibit increased 
probability to contain effective variants [68,71]. This is consistent 
with the outcome from previous directed protein evolution efforts 
[78] and with the results of the analysis of the transcriptional 
regulator variants evolved by gTME, which has shown that the 
emergence of significantly improved phenotypes usually requires 
multiple mutations [61,62,66,72,73]. An interesting observation is 
that the effective variants are very often N- or C-terminal truncations 
of the original regulator [61,66,67,71,77]. Since improved 
phenotypes upon expression of the truncated regulators occur in the 
presence of the full-length chromosomal copy of the regulator gene, it 
is likely that the engineered properties arise from the combined action 
of the evolved truncation and the full-length, wild-type protein [67]. 
Alternatively, the evolved truncations could be acting as anti-sigma 
factors [77]. In cases where a truncated factor is responsible for the 
emergence of the desired phenotype, it may be more efficient to 
perform random mutagenesis using the truncated rather the full-
length form of the protein [71].  
As anticipated, the effects of the evolved transcriptional regulator 
proteins are phenotype-specific, i.e. a regulator evolved to impart a 
specific property will, in general, be ineffective in improving another 
desirable phenotype. However, in cases where different phenotypes are 
linked to similar cellular pathways, regulators evolved for one 
phenotype may have similar effects on another. For example, mutants 
of rpoA (the gene encoding the α subunit of the E. coli RNA 
polymerase) that resulted in enhanced resistance to 1-butanol were 
also found capable of enhancing bacterial resistance to isobutanol, 1-
pentanol, and 3-pentanol [67]. For applications where two different 
unrelated cellular properties need to be simultaneously improved, an 
effective regulator for both properties can be evolved sequentially 
(first under conditions which are selective for property A and then the 
isolated variant can be mutated again and be subjected to selection for 
property B) or simultaneously (under conditions which are selective 
for both A and B) [61].      
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Figure 2. Schematic representation of the TRMR approach. (A). Synthetic DNA oligos in TRMR used for targeted gene up- and down-regulation in a microbial 
organism. These include gene-specific 5- and 3-terminal homology regions (grey), a gene-specific molecular barcode sequence (yellow), a blasticidin-S 
resistance marker for selecting for cells where successful recombination has occurred (blue), and a sequence which results, in general, in up- (green) or down-
regulation (red) of the gene located immediately downstream from this sequence. The sequence responsible for the up-regulation of gene expression contains 
the strong and inducible PLtetO-1 promoter [108] and a ribosome-binding site (RBS), while the sequence responsible for gene down-regulation contains an inert 
sequence. (B). Gene-specific synthetic oligos the lead to up- and down-regulation were generated for each one of the 4,077 genes of E. coli MG1655, yielding a 
total of 8,154 gene-targeting oligos. These oligos can then be introduced into living microbial cells by electroporation. Successful homologous recombination 
(selected for by the emergence of a resistance phenotype to the antibiotic blasticidin) can then lead to the creation of a microbial cell library, where each 
member expresses a different gene at higher or lower levels compared to the parental cells. Genes that have an enhancing or inhibitory role for a particular 
cellular property can then be identified by subjecting the TRMR-generated library to an appropriate genetic screen or selection, followed by sequencing or 
microarray analysis.          
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One of the most promising recent genome engineering approaches 
is MAGE [79]. A key advantage of this technology is that it is capable 
of generating high levels of genetic variability within multiple genomic 
loci simultaneously. MAGE utilizes synthetic single-stranded DNA 
oligonucleotides and the Redα/Redβ recombinase system from 
bacteriophage lambda in order to introduce point mutations, 
insertions, and deletions into targeted genomic loci of a microbial 
organism, such as E. coli (Figure 1). Synthetic oligos carrying 
homology regions with the targeted genomic regions along with the 
desired modifications are electroporated into modified bacterial 
strains, which are deficient in the DNA mismatch repair gene mutS 
and which express the components of the λ Red recombinase system. 
By performing repeated cycles of this process, at least one targeted 
region can be modified in approximately 30% of the cells of a 
bacterial population in a period of time as short as two hours [79]. By 
utilizing prototype mutagenic oligos, Wang et al. estimated that they 
could generate a population that contained close to 1010 variations in 
sequence compared to the parental cells within a day. The efficiency 
with which a particular modification is made depends on the degree 
and length of the homology region between the genomic target and 
the mutagenic oligo. Continuous MAGE cycles can be carried out 
until the desired genetic diversity is achieved, a factor which depends 
on the number of the genomic loci that will be modified and the 
degree of sequence diversity that will be introduced at each locus. 
Church and co-workers have already built a prototype device that 
automates the entire process, thus allowing rapid and easy generation 
of cell populations with very high levels of genetic diversity [79]. As 
the prices for custom oligonucleotide synthesis decrease, the 
applicability of this technology has the potential to become very 
broad.   
In order to demonstrate potential applications of MAGE in 
cellular programming, Wang et al. utilized the approach to enhance 
lycopene production in E. coli. The ribosome-binding sequences 
(RBSs) of twenty genes previously reported to affect lycopene 
production were randomized simultaneously, while four other such 
genes were targeted for inactivation by introduction of internal stop 
codon mutations. After performing 35 cycles of MAGE and screening 
for colonies with intense red pigmentation, the authors identified 
variants carrying RBS sequence modifications in four genes (dxs, dxr, 
idi, ispA) acting at the beginning and the end of the lycopene 
biosynthesis pathway, while three out of the four targets for 
inactivation were found to contain stop codons. Some of the isolated 
mutants were found to produce up to five-fold more lycopene than 
the parental bacterial strains. This corresponded to a yield of 9 mg/g 
of dry cell weight, higher than all other previously reported efforts 
[79]. In addition to enhanced metabolite production, MAGE has 
additionally been applied to bacterial genomic reprogramming in 
order to increase the incorporation of artificial amino acids into 
engineered proteins [80].  
More recent improvements of the technology [81-83] have 
resulted in increased efficiency of the MAGE process, which has 
allowed for efficient multi-loci insertion of longer sequences (>10 
bases) of DNA within a microbial genome (co-selection MAGE or 
CoS-MAGE) [84]. By using CoS-MAGE, Wang et al. were able to 
rapidly generate engineered E. coli, where the promoters of up to 
seventeen endogenous genes could be replaced with the strong and 
orthogonal-to-E. coli  T7  promoter.  Screening  for  enhanced 
production of the blue dye indigo in the generated T7 knock-in 
strains led to isolation of variants which can produce more than two-
fold more dye (~9 mg/g of dry cell weight) than the parental strain 
[84]. Despite the tremendous potential of MAGE and CoS-MAGE 
for application in inverse metabolic engineering efforts, one should 
consider that these approaches can only be applied in cases where 
genes relevant to a particular cellular property have already been 
identified previously by other techniques.                                    
 
Very recently, Gill and co-workers have developed an elegant 
methodology for constructing libraries of genetically modified 
microorganisms based on homologous recombination of pools of 
synthetic oligos [85]. To demonstrate the technology, the authors 
constructed two sets of polynucleotide cassettes each of which 
comprised 5 and 3 recognition sequences for homologous 
recombination with the genomic region immediately upstream of the 
start codon of each one of the 4,077 protein-coding genes of E. coli 
MG1655, interrupted by a gene-specific tracking sequence (barcode 
oligoncleotide), a blasticidin-S resistance marker for selection of 
successful recombination, and either an “up” cassette or a “down” 
cassette. The “up” cassette consisted of the sequences of the strong 
inducible promoter PLtetO-1 and a ribosome-binding site, whereas the 
“down” cassette comprised a transcriptionally and translationally inert 
sequence. The function of the up cassette was to generally up-regulate 
the expression of its target gene, while the down cassette was intended 
to down-regulate gene expression. After introduction of this library of 
polynucleotides into E. coli cells by electroporation and selection in 
antibiotic-containing media for clones where successful homologous 
recombination took place, the investigators were able to generate 
libraries of modified bacteria where each member contained a 
different up-regulated or down-regulated gene. This pool of 2 x 
4,077 = 8,154 mutant strains was subsequently subjected to selection 
for growth under conditions that normally do not permit growth of 
wild-type E. coli. These included media that contain salicin as the sole 
carbon source, media where the presence of D-fucose inhibits the 
ability of E. coli to utilize arabinose as a carbon source, and lethal 
concentrations of methylglyoxal (due to extensive oxidative damage), 
valine (due to feedback inhibition of the biosynthesis of leucine and 
isoleucine), and lignocellylosic hydrolysate (due to the presence of a 
cocktail of different growth inhibitors). Warner et al. reported that 
clones resistant to these conditions could emerge from the described 
TRMR libraries with frequencies 100-fold higher compared to the 
same cells lacking the introduced polynucleotide libraries [85]. 
Subsequently, the isolated clones could be easily characterized by 
DNA sequencing or microarray analysis using their corresponding 
molecular barcode sequences to identify the genes responsible for 
these complex phenotypes. In this manner, already known as well as 
novel genes involved in the emergence of these cellular properties 
could be identified. 
More recently, the same laboratory demonstrated that the ability 
of TRMR to assess the effect of up- and down-regulating individual 
genes on desired cellular properties at a genome-wide scale can be 
combined with the more in-depth search for the optimal transcription 
levels of genes relevant to a specific phenotype, which is offered by 
MAGE [86]. In that work, Sandoval et al. first used the TRMR 
libraries described above to identify genes which are involved in 
enhanced bacterial resistance to corn stover hydrolysate, acetate, and 
low pH, and to rank their relevance in these improved phenotypes. 
Then, they generated MAGE-like bacterial libraries, where the RBSs 
preceding the start codons of the genes identified as relevant in the 
previous step for the property in question were randomized. Based on 
the calculated efficiency of the process, the authors estimated that 
they could generate a population that contained a significant 
percentage of single, double, triple and quadruple mutants (i.e. 
mutants where the RBSs of one, two, three, and four genes were 
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modified, respectively) after thirteen cycles of recombination. These 
libraries were then re-subjected to genetic selection for improved 
phenotypes. In the case of the resistance phenotype to low pH, one 
clone was identified with improved growth characteristics compared 
both to the wild-type as well as the single mutant isolated by TRMR 
[86], thus demonstrating the potential power of combining the two 
methodologies. In the case of the other two selection conditions 
which were tested, however, no multi-gene mutant could be isolated 
that performed better than the single-gene variants identified by 
TRMR only. This highlighted the importance of epistatic 
interactions between the different genes associated with a particular 
phenotype. It remains to be seen whether such combinations of 
TRMR and MAGE will yield strains with improved characteristics 
for a variety of cellular properties.   
 
Another very interesting approach for generating complex 
phenotypes in microbes is “ribosome engineering”. Here, microbial 
cells are exposed to lethal concentrations of antibiotics that inhibit 
ribosomal function, such as chloramphenicol, rifampicin, 
streptomycin, kanamycin, spectinomycin, and others, and clones 
resistant to different levels of these compounds are selected [87]. 
Resistance to these antibiotics frequently arises from mutations in 
components comprising the ribosome, such as ribosomal proteins and 
RNA, or in other factors that affect mRNA translation, such as 
elements of the RNA polymerase. These changes can result in 
aberrant protein synthesis and in enhanced production of specific 
proteins. In certain cases, some of these overproduced proteins are 
encoded by genes which are normally in a dormant state. This altered 
proteome can in turn lead to the emergence of improved or even novel 
cellular properties. In one of the first demonstrations of the approach, 
Ochi and co-workers showed that mutations in rpsL, the gene 
encoding the ribosomal protein S12, which confer resistance to 
streptomycin in Streptomyces lividans and Streptomyces coelicolor 
result in increased production of the antibiotic actinorhodin [88,89]. 
Similar effects could also be observed with rpsL mutations that confer 
resistance to paromomycin [90]. Spontaneous mutations in rpsL can 
impart resistance to high levels of streptomycin and are rare as they 
occur with a frequency of 10-9-10-10 [87]. Low-level resistance to 
streptomycin can be acquired about 1,000 times more frequently by 
other types of mutations, such as in the gene rsmG, which encodes a 
16S RNA methyltransferase [91]. Such mutations can also lead to 
enhanced antibiotic production and, very interestingly, combination 
of the identified rpsL and rsmG mutations results in an additive 
increase in antibiotic yields [91].   
Streptomycin tolerance mutations can have a beneficial effect in 
the production of other useful products apart from actinorhodin in 
different bacteria. For example, mutants of Streptomyces 
chattanoogensis could produce up to 26-fold more fredericamycin, 
while mutants of Streptomyces antibioticus and Streptomyces 
lavendulae were able to overproduce formycin and actinomycin [92]. 
Furthermore, streptomycin-tolerant mutants of B. subtilis can 
accumulate enhanced amounts of enzymes, such as amylases and 
proteases [93]. Mutations in other translational machinery 
components, e.g. the gene rpoB that encodes a subunit of the RNA 
polymerase, which confer resistance to antibiotics other than 
streptomycin, such as rifampicin and gentamicin, can also have 
enhancing effects in antibiotic production [94]. Very importantly, the 
presence of mutations of this type in a specific bacterium can lead to 
the production of antibiotics which are not normally produced by the 
particular organism [95] or even in the production of completely 
novel compounds with antibiotic activities [96]. Finally, mutations 
conferring resistance to streptomycin, rifampicin, and gentamicin can 
also impart other types of industrially relevant phenotypes, such as 
enhanced tolerance to organic solvents and chemicals, as exemplified 
by strains of Pseudomonas putida whose growth could be sustained in 
significantly enhanced concentrations of toluene, m-xylene, 4-
hydroxybenzoate and others [97]. It should be mentioned that the 
mutations conferring resistance to the different antibiotics can be 
combined to provide synergistic effects in the desired phenotypes [98] 
and introduction of these mutations in industrial microbial strains can 
be as effective in improving desired phenotypes as in the laboratory 
organism in which they were originally identified [99].         
 
In cases where strains with improved cellular phenotypes have 
been created by one of the techniques discussed above, whole-genome 
recombination or “shuffling” can be applied to generate hybrid 
organisms that combine the beneficial mutations in a synergistic 
manner to further improve the desired properties [100]. Genome 
shuffling is typically carried out by a technique termed protoplast 
fusion [101]. Protoplast fusion involves enzymic removal of the cell 
wall (e.g. with lysozyme in bacteria), exposure to osmotic stabilizers 
so as to maintain the protoplast structure intact, and the addition of 
fusogenic chemical agents, such as polyethylene glycol (PEG), that 
induce the formation of membrane fusions between the generated 
protoplasts. Alternatively to the addition of PEG, protoplast fusion 
can take place more efficiently by electrofusion, i.e. by exposure to 
low-strength electric fields. It has been shown that repeated rounds of 
genome shuffling can result in the rapid emergence of complex 
phenotypes, such as improved production of the antibiotic tylosin 
from Streptomyces fradiae [100], tolerance to low pH of an industrial 
strain of Lactobacillus [102], degradation of pentachlorophenol in 
Sphingobium chlorophenolicum [103], butanol tolerance in E. coli 
[104], production of ethanol in yeast [105] etc. However, genome 
shuffling in Gram-negative bacteria, such as E. coli, is rather 
inefficient [104,106] and, thus, the technology needs to be improved 
before it can become one of widespread use.  
Kao and co-workers have recently attempted to address this issue 
by employing the fertility factor plasmid F to generate a system of 
continuous “sexual” exchange of genetic material between cells of a 
normally asexual organism, such as E. coli [107]. In this system, E. 
coli cells were engineered to become chromosomal DNA donors by 
incorporating the F factor into their genome along with a pair of 
sequences that act as origins of transfer, while deletion of the genes 
traS and traT, which encode for the proteins TraS and TraT that 
mediate surface exclusion, increased significantly the frequency of 
mating and DNA transfer. Winkler and Kao demonstrated that the 
emergence of a complex phenotype which can arise from mutations in 
multiple genomic loci that have a small beneficial impact, such as 
resistance to chloramphenicol, can be accelerated significantly in this 
system [107]. An important advantage of this approach is that 
evolution can be carried out continuously in liquid culture, a feature 
that makes the process considerably easier than classical genome 
shuffling.                 
 
4. Outlook  
 
Numerous studies have demonstrated that inverse metabolic 
engineering can be a very powerful approach for generating engineered 
strains with complex cellular properties. The availability of a variety 
of methods that allow the generation of large libraries of mutant 
organisms carrying different types of genetic profiles holds the 
potential to greatly expand the repertoire of phenotypes which can be 
Inverse metabolic engineering approaches 
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accessed. Analysis of the generated variants will subsequently provide 
a better understanding of the cellular processes which are critical for 
the emergence of the desired properties. The acquired knowledge can 
then be used as a starting point for guiding targeted pathway 
modifications through classical metabolic engineering or for 
additional rounds of inverse metabolic engineering, until 
improvements reach a high enough level to become attractive for 
academic and industrial applications.      
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